McNeil gelcaps patent
This article was originally published in The Tan Sheet
Executive Summary
Firm's OTCs that use gelatin capsule technology covered by '524 patent include Tylenol cough/cold products, not cough/cold offerings under the Motrin brand, as incorrectly stated in 1"The Tan Sheet" Aug. 5, 2002, p. 13...
You may also be interested in...
McNeil Gelatin Capsules Patent Infringed By Bayer, Jury Says
Two gelcap formulations of Bayer aspirin infringe a McNeil-PPC patent covering dual-colored, gelatin-coated caplets, a jury concluded July 26
Argenx’s Autoimmune Disease Blockbuster-In-Waiting Gets FDA Decision Date
The Belgium-Netherlands based company looks on course to gain US approval by the end of 2021.
Device Week, 05 March - Remote Monitoring Reimbursement, T-cell Diagnostics And A Digital Health Feature
In this week's podcast, managing editor Marion Webb discusses a new monthly digital health roundup which will soon feature on Medtech Insight. Managing editor Reed Miller discusses reimbursement difficulties as it applies to remote cardiac monitoring. UK-based reporter Barnaby Pickering gives an overview of an interview with the chief medical officer of Adaptive Biotechnologies about its new T-Detect platform.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: